Eiger BioPharmaceuticals, Inc. (EIGR)
(Delayed Data from NSDQ)
$10.50 USD
-0.22 (-2.05%)
Updated May 3, 2019 04:00 PM ET
After-Market: $10.53 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For EIGR
-
Eiger BioPharma: Q3 Earnings Snapshot
-
Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Eiger BioPharma: Q2 Earnings Snapshot
-
Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Eiger BioPharma: Q1 Earnings Snapshot
-
Eiger BioPharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
-
Eiger BioPharma: Q4 Earnings Snapshot
-
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
Eiger BioPharmaceuticals (EIGR) Reports Q3 Loss, Tops Revenue Estimates
-
Eiger BioPharma: Q3 Earnings Snapshot
-
Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss, Tops Revenue Estimates
-
Eiger BioPharma: Q2 Earnings Snapshot
-
Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
-
Eiger BioPharmaceuticals (EIGR) Reports Q1 Loss, Lags Revenue Estimates
-
Eiger BioPharmaceuticals (EIGR) Reports Q3 Loss, Tops Revenue Estimates
-
Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss, Tops Revenue Estimates
-
Eiger BioPharmaceuticals (EIGR) Reports Q4 Loss, Lags Revenue Estimates
-
Why Eiger BioPharmaceuticals (EIGR) Could Be Positioned for a Surge